Li Jiayu, Xin Yanguo, Lan Dihui, Zhang Yue, Hua Bing, Li Hongwei, Li Weiping, Chen Hui
Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Catheter Cardiovasc Interv. 2025 Jul;106(1):481-493. doi: 10.1002/ccd.31564. Epub 2025 May 4.
Cardiac magnetic resonance (CMR) is an effective tool for evaluating microvascular obstruction (MVO). This study aimed to compare the predictive effects of noninvasive methods, specifically early ST-segment resolution (STR) and quantitative flow ratio (QFR) in the detection of MVO in patients with ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PPCI).
A prospective cohort study enrolled 208 consecutive patients with acutely reperfused STEMI. The degree of STR was calculated postprocedure and predischarge after reperfusion. QFR measurements were obtained based on angiography, while CMR was performed within a median time of 5 days after revascularization to determine the presence of MVO. Clinical factors were enrolled to predict the incidence of MVO.
There were 126 patients identified to suffer MVO according to CMR. The area under the curve (AUC) identified QFR is the best predictor (AUC: 0.784, p < 0.001). The effect of QFR significantly increased beyond the baseline risk model with net reclassification improvement (NRI) 0.3373 (0.003-0.6716, p = 0.048). The MVO/left ventricular (LV) mass is 1.42 ± 2.28 in 126 patients with MVO according to CMR. Regression analysis indicated that postoperative STR (β = -0.267, p = 0.001) was a significant predictor of MVO/LV mass. Higher STR usually means lower infarct size, better cardiac systolic and diastolic function. Predischarge STR is closely correlated with the infarct size after 6-month follow-up (r = -0.509, p < 0.001).
In STEMI patients after PPCI, QFR exhibited a superior predictive capability for the occurrence of MVO. STR demonstrated a reliable predictive ability for MVO/LV mass in MVO populations, and exhibited correlations with heart function and infarct size during long-term follow-up.
心脏磁共振成像(CMR)是评估微血管阻塞(MVO)的有效工具。本研究旨在比较非侵入性方法,特别是早期ST段回落(STR)和定量血流比(QFR)对ST段抬高型心肌梗死(STEMI)患者在直接经皮冠状动脉介入治疗(PPCI)后检测MVO的预测效果。
一项前瞻性队列研究纳入了208例急性再灌注STEMI患者。在再灌注术后和出院前计算STR程度。基于血管造影获得QFR测量值,而CMR在血运重建后中位时间5天内进行以确定MVO的存在。纳入临床因素以预测MVO的发生率。
根据CMR确定有126例患者发生MVO。曲线下面积(AUC)显示QFR是最佳预测指标(AUC:0.784,p<0.001)。QFR的作用在基线风险模型基础上显著增加,净重新分类改善(NRI)为0.3373(0.003 - 0.6716,p = 0.048)。根据CMR,126例发生MVO的患者中MVO/左心室(LV)质量为1.42±2.28。回归分析表明术后STR(β = -0.267,p = 0.001)是MVO/LV质量的重要预测指标。较高的STR通常意味着梗死面积较小、心脏收缩和舒张功能较好。出院前STR与6个月随访后的梗死面积密切相关(r = -0.509,p<0.001)。
在PPCI后的STEMI患者中,QFR对MVO发生具有卓越的预测能力。STR在MVO人群中对MVO/LV质量显示出可靠的预测能力,并且在长期随访中与心脏功能和梗死面积相关。